methylprednisolone and cyclophosphamide
Showing 26 - 50 of 2,306
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)
Not yet recruiting
- Primary Membranous Nephropathy
- Obinutuzumab
- Oral prednisolone and cyclophosphamide
-
Garran, Australian Capital Territory, Australia
- +12 more
Nov 1, 2023
Mycophenolate Mofetil, Cyclophosphamide, Lupus Nephritis Trial in Changsha (Cyclophosphamide, Mycophenolate Mofetil)
Recruiting
- Mycophenolate Mofetil
- +2 more
- Cyclophosphamide
- Mycophenolate Mofetil
-
Changsha, Hunan, Chinathe Second Xiangya Hospital of Central South University
Aug 8, 2022
Glomerulonephritis, IGA Trial (Prednisolone, Prednisolone plus Cyclophosphamide)
Not yet recruiting
- Glomerulonephritis, IGA
- Prednisolone
- Prednisolone plus Cyclophosphamide
- (no location specified)
Aug 19, 2022
MEMBRANOUS NEPHROPATHY Trial in Madrid (TACROLIMUS, RITUXIMAB, METHYLPREDNISOLONE)
Completed
- MEMBRANOUS NEPHROPATHY
- TACROLIMUS
- +3 more
-
Madrid, SpainHospital 12 de Octubre
Jan 15, 2020
Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency Trial in Beijing (Plasma Exchange (PE), Methylprednisolone
Terminated
- Glomerulonephritis, IGA
- +3 more
- Plasma Exchange (PE)
- Methylprednisolone pulse
-
Beijing, Beijing, China
- +1 more
Sep 30, 2021
Systemic Sclerosis, Scleroderma Trial in Chicago (Rituximab, Fludarabine, Cyclophosphamide)
Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)
Not yet recruiting
- Idiopathic Membranous Nephropathy
- (no location specified)
Aug 22, 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- ANCA-Associated Glomerulonephritis
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Jul 23, 2023
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)
Recruiting
- Membranous Nephropathy - PLA2R Induced
- Rituximab, Cyclophosphamide, and Corticosteroids
-
Saint Petersburg, Russian FederationSt. Petersburg State Pavlov Medical University
Jan 7, 2023
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- anti-thymocyte globulin
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Jul 23, 2020
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- anti-thymocyte globulin
- +7 more
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jul 23, 2020
Diffuse Large B Cell Lymphoma Trial in Colchester, Canterbury, Nottingham (R-CHOP, R-CHOP + acalabrutinib)
Recruiting
- Diffuse Large B Cell Lymphoma
- R-CHOP
- R-CHOP + acalabrutinib
-
Colchester, Essex, United Kingdom
- +32 more
Oct 25, 2022
Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)
Recruiting
- Idiopathic Membranous Nephropathy
- Rituximab
- Modified Ponticelli regimen
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 23, 2023
Devic's Disease Trial in Chicago (Hematopoietic Stem Cell Transplantation, Cyclophosphamide, G-CSF)
Completed
- Devic's Disease
- Hematopoietic Stem Cell Transplantation
- +6 more
-
Chicago, IllinoisNorthwestern University, Feinberg School of Medicine
Feb 17, 2020
Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Cyclophosphamide
- +11 more
-
Houston, TexasM D Anderson Cancer Center
Nov 30, 2021
Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma Trial in
Active, not recruiting
- Ann Arbor Stage IIB Hodgkin Lymphoma
- +5 more
- Bleomycin Sulfate
- +11 more
-
Birmingham, Alabama
- +198 more
Sep 16, 2022
Henoch-Schoenlein Purpura Nephritis Trial in Nanjing (Prednisone, Cyclophosphamide(CTX), Mycophenolate mofetil(MMF))
Unknown status
- Henoch-Schoenlein Purpura Nephritis
- Prednisone
- +5 more
-
Nanjing, Jiangsu, ChinaNanjing Children's Hospital
Feb 25, 2020
Anti-Glomerular Basement Membrane Antibody Disease Trial in Worldwide (Imlifidase)
Completed
- Anti-Glomerular Basement Membrane Antibody Disease
- Imlifidase
-
Innsbruck, Austria
- +9 more
Feb 7, 2022
Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS
Recruiting
- Chronic Myeloid Leukemia (CML)
- +5 more
- CliniMACS CD34+ Reagent System
- +8 more
-
New York, New YorkColumbia University Medical Center
Jun 17, 2020
GVHD, Leukemia, Lymphoma Trial in Minneapolis (anti-thymocyte globulin, cyclophosphamide, cyclosporine)
Withdrawn
- Graft Versus Host Disease
- +2 more
- anti-thymocyte globulin
- +7 more
-
Minneapolis, MinnesotaUniversity of Minnesota Cancer Center
Dec 31, 2019
Renal Failure Trial in Boston (Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab, Combined bone marrow
Recruiting
- Renal Failure
- Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
- Combined bone marrow and kidney transplant
-
Boston, MassachusettsMassachusetts General Hospital
Jan 19, 2023
Kidney Failure, Kidney Transplant; Complications, Chimera Trial (other, procedure, drug)
Not yet recruiting
- Kidney Failure
- +2 more
- Bone Marrow Transplant
- +2 more
- (no location specified)
Jun 9, 2023
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +11 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 29, 2020